Coexpression networks identify brain region-specific enhancer RNAs in the human brain

Nature Neuroscience

Volumn 18, Issue 8, 2015, Pages 1168-1174

  Yao, Pu ^a   Lin, Peijie ^a   Gokoolparsadh, Akira ^a   Assareh, Amelia ^a   Thang, Mike W C ^b   Voineagu, Irina ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCER RNA; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FABP7; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG; CHROMATIN;

ADULT; ARTICLE; ASTROCYTE CULTURE; AUTISM; BODY MASS; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CHROMATIN IMMUNOPRECIPITATION; COEXPRESSION NETWORK; CONTROLLED STUDY; DNA SEQUENCE; ENHANCER REGION; FETUS; FRONTAL CORTEX; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN CHROMOSOME; HUMAN GENOME; HUMAN TISSUE; MEDULLA OBLONGATA; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; OCCIPITAL CORTEX; PRIORITY JOURNAL; RNA SEQUENCE; TEMPORAL CORTEX; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; BRAIN; CELL LINE; CHROMATIN; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; SEQUENCE ANALYSIS;

ADULT; BRAIN; CELL LINE; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHROMATIN; ENHANCER ELEMENTS, GENETIC; FETUS; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RNA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC;

EID: 84938337545     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4063     Document Type: Article

References (59)

1. Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101-108 (2012).
2. Thurman, R.E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012).
3. Sanyal, A., Lajoie, B.R., Jain, G. & Dekker, J. The long-range interaction landscape of gene promoters. Nature 489, 109-113 (2012).
4. Zhu, J. et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152, 642-654 (2013).
5. FANTOM Consortium and the RIKEN PMI and CLST (DGT) et al. A promoter-level mammalian expression atlas. Nature 507, 462-470 (2014).
6. 1000 Genomes Project Consortium et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
7. Ward, L.D. & Kellis, M. Interpreting noncoding genetic variation in complex traits and human disease. Nat. Biotechnol. 30, 1095-1106 (2012).
8. McCarroll, S.A., Feng, G. & Hyman, S.E. Genome-scale neurogenetics: methodology and meaning. Nat. Neurosci. 17, 756-763 (2014).
9. Gratten, J., Wray, N.R., Keller, M.C. & Visscher, P.M. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat. Neurosci. 17, 782-790 (2014).
10. Anney, R. et al. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 21, 4781-4792 (2012).
11. Anney, R. et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19, 4072-4082 (2010).
12. Wang, K. et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459, 528-533 (2009).
13. Weiss, L.A. et al. A genome-wide linkage and association scan reveals novel loci for autism. Nature 461, 802-808 (2009).
14. Kerin, T. et al. A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci. Transl. Med. 4, 128ra40 (2012).
15. Schizophrenia Working Group of the Psychiatric Genomics. C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
16. Barry, G. et al. The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol. Psychiatry 19, 486-494 (2014).
17. Mattick, J.S. The central role of RNA in human development and cognition. FEBS Lett. 585, 1600-1616 (2011).
18. Maston, G.A., Landt, S.G., Snyder, M. & Green, M.R. Characterization of enhancer function from genome-wide analyses. Annu. Rev. Genomics Hum. Genet. 13, 29-57 (2012).
19. Wenger, A.M. et al. The enhancer landscape during early neocortical development reveals patterns of dense regulation and co-option. PLoS Genet. 9, e1003728 (2013).
20. Kim, T.K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187 (2010).
21. Lam, M.T., Li, W., Rosenfeld, M.G. & Glass, C.K. Enhancer RNAs and regulated transcriptional programs. Trends Biochem. Sci. 39, 170-182 (2014).
22. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461 (2014).
23. Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
24. Core, L.J. et al. Analysis of nascent RNA identifes a unifed architecture of initiation regions at mammalian promoters and enhancers. Nat. Genet. 46, 1311-1320 (2014).
25. Wu, H. et al. Tissue-specifc RNA expression marks distant-acting developmental enhancers. PLoS Genet. 10, e1004610 (2014).
26. Vermunt, M.W. et al. Large-scale identifcation of coregulated enhancer networks in the adult human brain. Cell Reports 9, 767-779 (2014).
27. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identifcation of risk loci with shared effects on fve major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379 (2013).
28. Berndt, S.I. et al. Genome-wide meta-analysis identifes 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45, 501-512 (2013).
29. Yip, K.Y. et al. Classifcation of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors. Genome Biol. 13, R48 (2012).
30. Abrahams, B.S. et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol. Autism 4, 36 (2013).
31. O'Roak, B. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250 (2012).
32. O'Roak, B.J. et al. Exome sequencing in sporadic autism spectrum disorders identifes severe de novo mutations. Nat. Genet. 43, 585-589 (2011).
33. Sanders, S.J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012).
34. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012).
35. Cristino, A.S. et al. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol. Psychiatry 19, 294-301 (2014).
36. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
37. Langfelder, P., Zhang, B. & Horvath, S. Defning clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24, 719-720 (2008).
38. Zhang, B. & Horvath, S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, 17 (2005).
39. Hawrylycz, M.J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391-399 (2012).
40. Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519-523 (2011).
41. Kang, H.J. et al. Spatio-temporal transcriptome of the human brain. Nature 478, 483-489 (2011).
42. Irimia, M. et al. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell 159, 1511-1523 (2014).
43. Uddin, M. et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742-747 (2014).
44. Willsey, A.J. et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155, 997-1007 (2013).
45. Kleinjan, D.A. et al. Long-range downstream enhancers are essential for Pax6 expression. Dev. Biol. 299, 563-581 (2006).
46. Mu, L. et al. SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis. J. Neurosci. 32, 3067-3080 (2012).
47. Eisinger, B.E., Driessen, T.M., Zhao, C. & Gammie, S.C. Medial prefrontal cortex: genes linked to bipolar disorder and schizophrenia have altered expression in the highly social maternal phenotype. Front. Behav. Neurosci. 8, 110 (2014).
48. Maekawa, M. et al. Polymorphism screening of brain-expressed FABP7, 5 and 3 genes and association studies in autism and schizophrenia in Japanese subjects. J. Hum. Genet. 55, 127-130 (2010).
49. Shimamoto, C. et al. Functional characterization of FABP3, 5 and 7 gene variants identifed in schizophrenia and autism spectrum disorder and mouse behavioral studies. Hum. Mol. Genet. 23, 6495-6511 (2014).
50. Core, L.J. et al. Analysis of nascent RNA identifes a unifed architecture of initiation regions at mammalian promoters and enhancers. Nat. Genet. 46, 1311-1320 (2014).
51. Takahashi, H., Lassmann, T., Murata, M. & Carninci, P. 5′ end-centered expression profling using cap-analysis gene expression and next-generation sequencing. Nat. Protoc. 7, 542-561 (2012).
52. Lassmann, T., Hayashizaki, Y. & Daub, C.O. TagDust-a program to eliminate artifacts from next generation sequencing data. Bioinformatics 25, 2839-2840 (2009).
53. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
54. Trapnell, C., Pachter, L. & Salzberg, S.L. TopHat: discovering splice junctions with RNA-seq. Bioinformatics 25, 1105-1111 (2009).
55. Quinlan, A.R. & Hall, I.M. BEDTools: a fexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
56. Wang, K., Li, M. & Bucan, M. Pathway-based approaches for analysis of genome-wide association studies. Am. J. Hum. Genet. 81, 1278-1283 (2007).
57. Parikshak, N.N. et al. Integrative functional genomic analyses implicate specifc molecular pathways and circuits in autism. Cell 155, 1008-1021 (2013).
58. Voineagu, I. et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474, 380-384 (2011).
59. Hochberg, Y. & Benjamini, Y. More powerful procedures for multiple signifcance testing. Stat. Med. 9, 811-818 (1990).